• menu
    Market Place Market Place
    Sourcing support Sourcing Support
    API / FDF
    Excipients
    Services
    Developments
    News
    Market Intel
    #Phispers
    #SpeakPharma
    #LearnMore

    NEWS

    DRUGS & DEVELOPMENTS

    MARKET INTEL by PharmaCompass

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.
    All News #Library

    Sydnexis To Unveil Phase 3 STAR Trial Data On SYD-101 At ARVO

    PHARMIWEB

    Rezolute Presents Phase 3 Sunrize Study Results On Ersodetug

    FIRSTWORD PHARMA

    FDA Approves Pfizer-Arvinas Breast Cancer Drug Despite Weak Data

    ENDPOINTS

    Weight-loss drugs may also help cut alcohol intake: Study

    ECONOMICTIMES

    US FDA approves Axsome`s drug for Alzheimer`s-related agitation

    REUTERS

    Novartis Reveals North Carolina Factory In $23B US Expansion

    ENDPOINTS

    Vector Science Files Patent for Microneedle Intratumoral Platform

    FIRSTWORD PHARMA

    Restore Vision: RV-001 Optogenetic Therapy Interim Results

    PR NEWSWIRE

    Oberland Bio Secures CHF 2.5M Funding To Expand Biotech

    PR NEWSWIRE

    New Data Reveals Sof-Skn`s Efficacy In Patient Samples

    FIRSTWORD PHARMA

    New CAR-T Therapy Lets Some Cancer Patients Skip Chemo

    REUTERS

    INOVIO to Report Q1 2026 Financial Results on May 13

    PR NEWSWIRE

    FDA Taps Szarama to Head CBER as Prasad`s Tumultuous Tenure Ends

    BIOSPACE

    Zealand Pharma to Hold EGM on May 26

    GLOBENEWSWIRE

    Zealand Pharma Board Proposes Camilla Sylvest For Director Role

    GLOBENEWSWIRE

    Xenon Pharma Discloses Inducement Grants Per Nasdaq LR 5635(C)(4)

    GLOBENEWSWIRE

    Taysha Grants Inducement Under Nasdaq Rule 5635(c)(4)

    GLOBENEWSWIRE

    Spyre Therapeutics Announces Grants Of Inducement Awards

    GLOBENEWSWIRE

    Samsung Biologics workers begin 5-day strike over wage disputes

    ENDPOINTS

    FDA Expands Access to Investigational Drug for Pancreatic Cancer

    FIRSTWORD PHARMA

    Phathom Pharma Showcases VOQUEZNA At DDW 2026 Conference

    FIRSTWORD PHARMA

    US FDA Approves Pfizer, Arvinas` Breast Cancer Drug

    REUTERS

    Pelthos Therapeutics Reports Q1 2026 Results on May 14, 2026

    GLOBENEWSWIRE

    Orchard Pharma Receives Innovation Passport For OTL-201

    PHARMIWEB

    Onco-Inno Boosts PNKP Inhibitor Production With Dalton Pharma

    PHARMIWEB

    Noema Pharma To Unveil Cendifensine Phase 2A Results

    FIRSTWORD PHARMA

    NewAmsterdam Issues Inducement Grants Under Nasdaq Rule

    GLOBENEWSWIRE

    Neurocrine Biosciences Shows Durable Hormone Control

    PR NEWSWIRE

    Moderna Unveils Q1 2026 Financials And Business Updates

    FIRSTWORD PHARMA

    Moderna In Talks With FDA Over Phase 4 Covid Vaccine Data

    ENDPOINTS

    Moderna Exceeds Revenue Expectations, Faces Litigation Impact

    BIOSPACE

    Merck KGaA Launches Phase 3 Enpatoran Trials for Cutaneous Lupus

    INDPHARMAPOST

    MapLight Therapeutics Completes ZEPHYR Phase 2 Enrollment

    FIRSTWORD PHARMA

    Lakewood-Amedex Announces Positive Diabetic Foot Ulcer Data

    PR NEWSWIRE

    Kodiak Pipeline & KSI-101 Data at Key Conferences

    PR NEWSWIRE

    J&J Discontinues 2 CAR-T Lymphoma Therapies Due To Market Changes

    ENDPOINTS

    Intellia Therapeutics Awards Inducement Grants per Nasdaq Rules

    GLOBENEWSWIRE

    Inflarx To Report First Quarter 2026 Results On May 7, 2026

    GLOBENEWSWIRE

    IDEAYA Bio Announces Inducement Grants Under Nasdaq LR 5635(C)(4)

    PR NEWSWIRE

    Equillium Issues Inducement Grants Under Nasdaq Rule 5635(c)(4)

    GLOBENEWSWIRE

    Dianthus Issues Nasdaq-Compliant Inducement Grants

    GLOBENEWSWIRE

    Diakonos Oncology Presents Phase 1 Pancreatic Cancer Study

    FIRSTWORD PHARMA

    Damora Therapeutics Grants Inducements Under Nasdaq Rule

    GLOBENEWSWIRE

    Corcept`s ALS Drug Boosts 2-Year Survival in Phase 3

    BIOSPACE

    Celcuity`s VIKTORIA-1 Phase 3 Trial Hits Primary Endpoint

    GLOBENEWSWIRE

    Candel Therapeutics Grants Inducements Under Nasdaq Rules

    GLOBENEWSWIRE

    Avalyn Closes Ipo With Full Underwriters` Share Purchase Exercise

    FIRSTWORD PHARMA

    Astrazeneca Breast Cancer Drug Fails FDA Advisory Committee

    BIOSPACE

    Amgen Launches Trial for Switchers from Rival Obesity Drugs

    ENDPOINTS

    ADC Therapeutics Grants New Employees Under Inducement Plan

    PR NEWSWIRE

    DINAMIQS Secures Swissmedic License For Viral Vector Production

    PRESS RELEASE

    Merck & Co.`s Keytruda posts $8B in Q1 as Qlex picks up steam

    FIRSTWORD PHARMA

    Early sales of Lilly’s obesity pill appear to trail Novo’s

    ENDPOINTS

    Fesarius Therapeutics Showcases DermiSphere hDRT Uniqueness

    PR NEWSWIRE

    A.D.A.M. Innovations Empowers NTT Precision Medicine

    GLOBENEWSWIRE

    HHS appeals ruling on Kennedy’s vaccine policies

    RAPS

    Zealand Pharma To Present Q1 2026 Financial Results

    GLOBENEWSWIRE

    YD Bio Limited Reports Full Year 2025 Financial Results

    GLOBENEWSWIRE

    XTL Bio Acquires Psychedelic Biotech; Wuxi Apptec`s Q1 Revenue Up

    ENDPOINTS

    VIVUS Announces QSIVA Price Reduction Across Nordics And Poland

    GLOBENEWSWIRE

    Copyright © 2026 LePro PharmaCompass OPC Private Limited, All rights reserved.